C. Provisions

Provisions and liabilities are recognized in the period
when it becomes probable that there will be a future
outflow of funds resulting from past operations
or events and the amount of cash outflow can be
reliably estimated. The timing of recognition and
quantification of the liability requires the application
of judgement to existing facts and circumstances,
which can be subject to change. The carrying
amounts of provisions and liabilities are reviewed
regularly and revised to take account of changing
facts and circumstances.

D. Impairment of non-financial assets

The Company assesses at each reporting date
whether there is an indication that an asset may
be impaired. If any indication exists, the Company
estimates the asset's recoverable amount. An asset's
recoverable amount is the higher of an asset's or
Cash Generating Units (CGU's) fair value less costs
of disposal and its value in use. It is determined
for an individual asset, unless the asset does not
generate cash inflows that are largely independent
of those from other assets or a groups of assets.
Where the carrying amount of an asset or CGU
exceeds its recoverable amount, the asset is
considered impaired and is written down to its
recoverable amount.

In assessing value in use, the estimated future cash
flows are discounted to their present value using
pre-tax discount rate that reflects current market
assessments of the time value of money and the
risks specific to the asset. In determining fair value
less costs of disposal, recent market transactions
are taken into account, if no such transactions can
be identified, an appropriate valuation model is used.

E. Impairment of financial assets

The impairment provisions for financial assets
are based on assumptions about risk of default
and expected cash loss rates. The Company
uses judgment in making these assumptions and
selecting the inputs to the impairment calculation,
based on Company's past history, existing market
conditions as well as forward looking estimates at
the end of each reporting period.

(' in La [•

2-3 years More than To

During financial year, the Company has converted 25,00,000 share warrant into equity shares of face value ' 1/- each to certain parties under
preferential allotment as approved by the shareholders in accordance with Chapter V of the Securities and Exchange Board of India (issue
of Capital and Disclosure Requirements) Regulations, 2018. The Equity Shares were issued @ ' 169/- per Equity Share (including a share
premium of ' 168/- per share).

During financial year, the Company has allotted 6,00,000 Equity Shares of ' 1 each to certain parties under Employee Stock Purchase
Scheme 2024 as approved by the shareholders in accordance with Chapter V of the Securities and Exchange Board of India (issue of Capital
and Disclosure Requirements) Regulations, 2018. The Equity Shares were issued @ ' 1/- per Equity Share (including a share premium of
' Nil per share).

b. Terms/rights attached to equity shares

The company has only one class of equity shares having a per value of ' 1 per share (previous year ' 1 per share). Each Equity shares is
entitled to one vote per share. In the event of liquidation of the company, the holders of equity shares will be receive remaining assets
of the company, after distribution of all preferential amount. The distribution will be in proportion to the number of equity shares held by
the shareholders.

NOTE 32 - DETAILS OF DUES TO MICRO AND SMALL ENTERPRISES AS DEFINED UNDER THE MSMED ACT, 2006

Dues to micro and small enterprises as defined under MSMED Act, 2006, on the basis of certificate received from vendors the company has
informed under the Micro, Small and Medium Enterprises Development Act, 2006. In Some of the cases, date of acceptance may be differ due to
quality of materials, hence interest provision under the said act not booked.

NOTE 33 - SEGMENT INFORMATION

i) Primary (Business) Segment

In accordance with the requirements of Accounting Standard 17 "Segment Reporting” issued by the ICAI, the Company's business consist
of one reportable segment i.e. Seat & Berth, Recorn Densified Thermal Bonded Blocks, Recorn Wadding, Comperg, Foldable Mattress.
Hence no separate disclosures pertaining to attributable Revenues, Profits, Assets, Liabilities, Capital Employed are given.

ii) Secondary (Geographical) Segment

Secondary segment reporting is performed on the basis of geographical location of the Customers The operation of the Company comprises
domestic sales and export sales. The export sale consideration is not materialized hence no separate disclosure pertaining to attributable
Revenues, Profits, Assets, Liabilities, Capital Employed are given.

As per section 135 of the Companies Act, 2013, a company, meeting the applicability threshold, needs to spend 2% of its average net profit for
the immediately preceding three financial years on corporate social responsibility (CSR) activities. The areas for CSR activities are eradicating
poverty , hunger and malnutrition, promoting healthcare and improvement in education. A CSR committee has been by the company as per the
Act. The funds were primarily allocated to a corpus and utilized through the year on there activities which are specified in schedule VII of the
Companies Act 2013:

The Company's principal financial assets include trade & other receivables, and cash & cash equivalents that derives directly from its operations.
The Company's principal financial liabilities comprise trade & other payables and short term borrowings. The main purpose of majority of these
financial liabilities is to manage working capital of the Company.

The Company is exposed to credit risk, market risk and liquidity risk. The Company's senior management oversees the management of these
risks. The Company's financial risk activities are governed by appropriate policies and procedures and financial risks are identified, measured
and managed in accordance with the Company's policies and risk objectives. The below note explains the sources of risk which the Company is
exposed to and how the entity manage the risk:

A) Credit Risk

Credit risk is the risk that counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial
loss. The Company is exposed to credit risk from its operating activities (primarily trade receivables) and from its investing activities,
primarily cash & cash equivalents.

i) Trade Receivables

Customer credit risk is managed in accordance with the Company's established policy, procedures and controls relating to customer
credit risk management. Credit quality of a customer is assessed based on individual credit limits are defined in accordance
with this assessment. Outstanding customer receivables are regularly monitored through credit lock and release effectively
manage the exposure.

An impairment analysis is performed at each reporting date on an individual basis for major customers In addition,a large number
of minor receivables are grouped into homogenous groups and assessed for impairment collectively. The calculation is based on
historical data. The Company does not hold any collateral as security. The Company evaluates the concentration of risk with respect to
trade receivables as low, as most of its external customers are established players in their industry.

The Company determines the allowance for credit losses based on historical loss experience adjusted to reflect current and estimated
future economic conditions. The Company considered current and anticipated future economic conditions relating to industries the
Company deals with and the countries where it operates. In calculating expected credit loss, the Company has also considered related
credit information for its customer, that's available in public domain to estimate the probability of default in future.

ii) Cash and Cash Equivalents and Other Financial Assets

Credit risk from balances with banks is managed by the Board of Directors in accordance with the Company's policy. Investment of
surplus funds are made for short-term in deposit with banks. Investments and Bank deposits are reviewed by the Board of Directors
on a quarterly basis. Credit risk arising from short term liquid fund, cash and cash equivalents and other balances with banks is limited
and no collaterals are held against these because the counterparties are banks.

Other financial assets mainly include security deposits & other receivables. There are no indications that defaults in payment
obligations would occur in respect of these financial assets.

B) Market Risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market
prices. Market risk comprises three types of risk: such as commodity risk, foreign currency risk and equity price risk. Financial instruments
affected by market risk include FVTPL investments, trade payables, trade receivables, borrowings, other receivables etc.

i) Commodity Risk

Commodity risk for the Company is mainly related to availability of raw materials at right price which drives the prices of Finished
Goods. Most of these input materials are procured from approved vendors and subject to price negotiations. In order to mitigate the
risk associated with raw material and components prices, the Company manages its procurement through productivity improvements,
expanding vendor base and constant pricing negotiation with vendor The Company renegotiates the prices with its customers in case
there is more than normal deviation in the prices of its major raw materials. Additionally, the processes and policies related to such
risks are reviewed and controlled by senior management team.

ii) Foreign Currency Risk

Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign
exchange rates. The risk of fluctuations in foreign currency exchange rates on its financial liabilities including trade and other payables
etc. Hence, variation in the Foreign exchange rate would have reasonable impact on the profit or loss / equity of the Company.
Net foreign currency exposure also reviewed by the Board of Directors on a quarterly basis.

Foreign Currency Sensitivity Analysis

The Company is exposed to the currencies USD & EURO on account of outstanding receivables ( ) and payables (-). The Company's net
exposure to foreign currency risk at the end of the reporting period expressed in respective currencies given below:

Foreign currency exposures are not hedged by derivative instrument as on the March 31, 2025 is Nil [Previous Year is Nil).

iii) Equity Price Risks

Equity price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in
equity prices, whether those changes are caused by factors specific to the individual financial instrument or its issuer, or by
factors affecting all similar financial instrument straded in the market.

The Company only invests in the equity shares of the subsidiary as part of the Company's overall business strategy and policy.
The Company manages the equity price risk through placing limits on individual and total equity investment in the subsidiary. The
Company's investment in quoted equity instruments (other than subsidiaries) is Nil.

C) Liquidity Risk

Liquidity risk is defined as a risk that the Company will not be able to meet its obligations on time or at a reasonable price. An effective
liquidity risk management takes into consideration in maintaining optimum level of cash and cash equivalents and the availability of funding
through an credit facilities at a reasonable cost to meet the obligation when due. Additionally, the processes and policies related to such
risks are reviewed and controlled by senior management team. Management continuously reviews the actual cash flows and forecasts the
expected cash flows to monitor the liquidity position. All the current financial liabilities of the Company are due to be paid with in twelve
months from the date from the Balance sheet date. All non-current financial liabilities are due to be paid in more than twelve months from
the Balance sheet date. However the interest component of all the non-current financial liabilities if any will be payable as and when due,
which may be with in twelve months from the date of Balance sheet date.

NOTE 40

Out of the total debtors of ' 6,159.27 Lakhs As at March 31, 2025, ' 554.46 Lakhs has more than one year at the year end. The management is in
discussion with these debtors to expedite the recoverability of the above aforesaid outstanding amounts and believes that the entire amount is
fully recoverable. Further, Company has recovered an amount of ' 123.41 Lakhs from these outstanding dues till date.

NOTE 41 - OTHER STATUTORY INFORMATION

a. The Company does not have any Benami property, where any proceeding has been initiated or pending against the Group for holding any
Benami property.

b. The Company does not have any transactions with struck off companies.

c. The Company has not traded or invested in Crypto currency or Virtual Currency during the financial year.

d. The Company does not have any such transaction which is not recorded in the books of accounts that has been surrendered or disclosed as

income during the year in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of

the Income Tax Act, 1961.

e. The Company has not been declared wilful defaulter by any bank or financial institution or government or any government authority.

f. The Company has complied with the number of layers prescribed under the Companies Act, 2013.

NOTE 42 - Sundry Debtors, Sundry Creditors, loans & advances and outstanding balance are subject to confirmation and reconciliation.

NOTE 43 - Previous Year Figures have been reclassified/recast to conform to this year's classification.

As per our report of even date For and on behalf of the Board of Directors

For Anil Bansal & Associates Saleh N. Mithiborwala Vali N. Mithiborwala

Chartered Accountants Whole Time Director / CFO Whole Time Director

Firm Registration Number: 100421W DIN: 00171171 DIN: 00171255

Anil Bansal Hemali Rachh

Partner Company Secretary

Membership No. 043918 M No. A64025

Place: Mumbai
Date: 27-05-2025